DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Negative impactCompany

Sanofi India's petition to quash criminal proceedings dismissed by Supreme Court

CNBC-TV18 1 hr ago·8 Sept 2026, 11:43 am

The Supreme Court has rejected Sanofi India's request to halt criminal proceedings against the company. This ruling means the legal case will continue in a lower court, where the company faces allegations related to past business practices.

For investors, this development is neutral. The dismissal of the petition does not resolve the underlying legal dispute but confirms that the matter remains active. The stock's recent minor decline suggests the market is focusing on the immediate legal outcome rather than the company's core business performance.

Investors should now watch for updates from the lower court regarding the next steps in the case. The resolution of these proceedings will be the key factor influencing the stock's future movement.

Affected stocks

Bearish1 stock

Sanofi India

SANOFI Bearish

₹3,122.00

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Sanofi India (SANOFI).
Category: Company.
AI reads the tone as negative (potentially bearish) for the stock.

Why it matters

A routine update for Sanofi India. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.